Navigation Links
Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting
Date:6/1/2009

inc.com/" target="_new">www.peregrineinc.com.

Bavituximab Presentation Details:

Preliminary data from a Phase II clinical trial evaluating bavituximab in combination with docetaxel in advanced breast cancer patients will be the subject of an oral presentation at 10:30 AM EDT on June 1, 2009. A second presentation detailing preliminary results from a Phase I clinical trial evaluating bavituximab as solo therapy in patients with advanced refractory cancer will be discussed in a poster session from 1:00 PM to 5:00 PM EDT, also on June 1, 2009.

Title: Phase II study of bavituximab plus docetaxel in patients with locally advanced or metastatic breast cancer.

Authors: D. Tabagari, G. Nemsadze, M. Jincharadze, M. Janjalia, J. Shan

Time: Monday June 1, 10:30 AM

Location: Level 4, Valencia Room, W415A

Abstract No: 3005

Title: Phase I study of bavituximab, a novel anti-phosphatidylserine monoclonal antibody in patients with advanced refractory cancer: Preliminary results.

Authors: N. K. Ibrahim, L. Wong, L. Rosen, J. Shan

Time: Monday June 1, 1:00 PM to 5:00 PM

Location: Level 2, West Hall C

Abstract No: 1080

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information ab
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Clinical Data on Peregrines Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting
2. Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial
3. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
4. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
5. Peregrine Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
6. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
7. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
8. Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz
9. Peregrine Pharmaceuticals Enters Into a Loan Agreement for up to $10 Million
10. Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results
11. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Hayden-McNeil is pleased to announce ... materials for smaller courses. This program is specifically designed ... students. , “I’m very excited about offering our ... instructors,” said Jeff McCarthy, Hayden-McNeil president. “By working with ... part to make education both more effective and affordable.” ...
(Date:5/5/2015)... Israel , May 5, 2015  Tikcro ... Company was approved to continue trading on OTCQB  ... OTCQB Marketplace allows for a continuous ... broker-dealers. Investors can have real-time quotes and market ... The OTCQB Marketplace includes U.S. and ...
(Date:5/5/2015)... May 5, 2015 Reprints Desk, Inc., a ... on-demand access to scientific, technical and medical (STM) content, ... Association of Southeastern Research Libraries (ASERL) . ... located across 11 southeastern states. Founded in 1956, ASERL ... programs to address the continually changing needs of its ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 A comment ... a wide range of key photonics technologies – regulations ... competitiveness of U.S. industry. To help the community understand ... 12 May on the proposed changes to U.S. ... covered by International Traffic in Arms Regulations (ITAR). , ...
Breaking Biology Technology:Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 2Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 3Association of Southeastern Research Libraries Partners with Reprints Desk to Improve Access for Hard-to-Find Materials 4Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4
... Other important parameters for optimizing electroporation., , , , , , , ... , Pulse length , , ... Adjustment , of the electroporation buffer , ... Influence , of temperature , Influence , ...
... , , , , , , Other important parameters for optimizing electroporation., , ... Field strength , , Pulse ... field pulses , Adjustment , ... of DNA/RNA , Influence , ...
... , and the Brinkmann Bottletop Buret ... , , Bottletop dispensers are used in the ... solvents from glass or stainless steel containers. These dispensers , ... , substances which may disturb trace analysis, have cytotoxic ...
Cached Biology Technology:Optimizing electroporation parameters 2Optimizing electroporation parameters 3Optimizing electroporation parameters 4Optimizing electroporation parameters 5Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 2Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 3Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 4Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 5Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 6Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 7Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 8Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 9Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 10Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 11Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 12Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 13Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 14Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 15Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 16Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 17Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 18Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 19Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 20Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 21Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 22Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 23Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 24Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 25Chemical Stability of the Brinkmann Bottletop Dispenser , and the Brinkmann Bottletop Buret 26
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:4/2/2015)... At its 2015 ACMG Annual Clinical Genetics ... the American College of Medical Genetics and Genomics (ACMG) ... Board.  Members of the ACMG Board of Directors serve ... advancing its policies and programs. ACMG is the national ... an eventful time in medical genetics and genomics.  We ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... with a probiotic strain of E. coli bacteria could help ... infection that may be associated with Crohn,s disease. Researchrs ... in the April 2011 issue of the journal Applied and ... that affects the gastrointestinal tract and is believed to develop ...
... In what could be a potential breakthrough in the ... design of new drugs, scientists have engineered a new protein ... based on a naturally occurring protein in the body that ... cause inflammation and other side effects at the dosages needed ...
... Reducing Emissions from Deforestation and Forest Degradation ,Plus, ... aims to financially compensate landowners and stewards for ... promoting forest conservation, sustainable forest management and the ... implemented correctly, REDD+ has the potential to generate ...
Cached Biology News:Intelligent design: Engineered protein fragment blocks the AIDS virus from entering cells 2REDD+, Technical, Socioeconomic and Political Dimensions 2REDD+, Technical, Socioeconomic and Political Dimensions 3
... is a simple high performance method for ... detergents without significant dilution of protein solution. ... the Detergent-OUT Spin column and collect detergent ... is suitable for removing detergents from a ...
... derived from frozen embedded tissue blocks, which ... to ensure the highest quality. Tissues of ... block, sectioned at a thickness of 7 ... are large (3-5 mm in diameter) in ...
... Zyagen tissue microarrays are derived from Paraffin ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... on coated slides. Sections are large (3-5 ...
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... on coated slides. Sections are large (3-5mm ...
Biology Products: